| Shukra Pharmaceuticals Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524632 |
NSE Symbol : - |
P/E(TTM) : 142.63 |
|
ISIN Demat : INE551C01044 |
Div & Yield% : 0.03 |
EPS(TTM) : 0.27 |
|
Book Value(₹) : 1.50 |
Market Cap(₹Cr) : 1,686.27 |
Face Value(₹) : 1.00 |
| Particulars | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 39.13 | 5.88 | 5.39 | 13.27 | 10.58 | 5.56 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 39.13 | 5.88 | 5.39 | 13.27 | 10.58 | 5.56 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 0.82 | 1.71 | 1.11 | 1.47 | 1.01 | 1.02 |
| Total Income | 39.95 | 7.59 | 6.50 | 14.74 | 11.59 | 6.57 |
| Total Expenditure | 12.00 | 6.30 | 4.07 | 5.95 | 6.65 | 4.89 |
| PBIDT | 27.95 | 1.29 | 2.43 | 8.78 | 4.94 | 1.68 |
| Interest | 0.28 | 0.29 | 0.27 | 0.27 | 0.15 | 0.11 |
| PBDT | 27.67 | 1.01 | 2.16 | 8.51 | 4.79 | 1.57 |
| Depreciation | 0.84 | 0.81 | 0.79 | 0.94 | 0.70 | 0.70 |
| Tax | 4.11 | 0.00 | 0.41 | 2.18 | 0.89 | 0.29 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 2.35 | -2.18 | -0.06 | 0.00 | 0.04 | 0.05 |
| Reported Profit After Tax | 20.36 | 2.38 | 1.03 | 5.39 | 3.16 | 0.54 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 20.36 | 2.38 | 1.03 | 5.39 | 3.16 | 0.54 |
| EPS (Unit Curr.) | 0.47 | 0.05 | 0.02 | 0.12 | 0.72 | 0.12 |
| EPS (Adj) (Unit Curr.) | 0.47 | 0.05 | 0.02 | 0.12 | 0.07 | 0.01 |
| Calculated EPS (Unit Curr.) | 0.47 | 0.05 | 0.02 | 0.12 | 0.72 | 0.12 |
| Calculated EPS (Adj) (Unit Curr.) | 0.47 | 0.05 | 0.02 | 0.12 | 0.07 | 0.01 |
| Calculated EPS (Ann.) (Unit Curr.) | 1.86 | 0.22 | 0.09 | 0.49 | 2.89 | 0.49 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 1.86 | 0.22 | 0.09 | 0.49 | 0.29 | 0.05 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 43.79 | 43.79 | 43.79 | 43.79 | 43.79 | 43.79 |
| Reserve & Surplus | 0.00 | 22.02 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 1.00 | 1.00 | 1.00 | 1.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 71.43 | 21.94 | 45.08 | 66.16 | 46.69 | 30.22 |
| PBDTM(%) | 70.71 | 17.18 | 40.07 | 64.13 | 45.27 | 28.24 |
| PATM(%) | 52.03 | 40.48 | 19.11 | 40.62 | 29.87 | 9.71 |